Clinical Trial Detail

NCT ID NCT01674140
Title S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements yes
Sponsors Southwest Oncology Group
Indications

Her2-receptor negative breast cancer

Therapies

Goserelin

Anastrozole

Letrozole

Leuprolide

Everolimus

Tamoxifen

Exemestane

Age Groups: adult

Additional content available in CKB BOOST